Stock Fundamentals

Company Information

Company Name
Acurx Pharmaceuticals LLC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US00510M1045
CIK: 0001736243
CUSIP: 00510M104
Currency: USD
Full Time Employees: 4
Phone: 917 533 1469
Fiscal Year End: December
IPO Date: Jun 25, 2021
Description:

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Address:

259 Liberty Avenue, Staten Island, NY, United States, 10305

Directors & Officers

Name Title Year Born
Mr. Robert J. DeLuccia Co-Founder & Executive Chairman 1946
Mr. David P. Luci CPA, Esq., J.D. Co-Founder, President, CEO, Corporate Secretary & Director 1967
Mr. Robert G. Shawah CPA Co-Founder & CFO 1967
Dr. Michael H. Silverman B.Sc., F.A.C.P., FACR, M.B.A., M.D. Medical Director 1948

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 06, 2025 David P Luci N/A Purchase 2.46K $20.20 $49.75K
Jan 06, 2025 Joseph C Scodari N/A Purchase 1.23K $20.20 $24.87K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Jane Street Group LLC 54.64K Mar 31, 2026 1.27% $0.00 408.63%
Vanguard Capital Management, LLC 31.10K Mar 31, 2026 0.72% $0.00 0.00%
Geode Capital Management, LLC 24.82K Mar 31, 2026 0.58% $0.00 99.88%
Vanguard Group Inc 23.28K Dec 31, 2025 0.54% $0.00 0.00%
CAMBRIDGE Invest RESEARCH ADVISORS, INC. 20.00K Mar 31, 2026 0.47% $0.00 0.00%
Vanguard Fiduciary Trust Co 16.21K Mar 31, 2026 0.38% $0.00 0.00%
Prospect Financial Services Llc 13.79K Mar 31, 2026 0.32% $0.03 -30.49%
Morgan Stanley - Brokerage Accounts 6.50K Mar 31, 2026 0.15% $0.00 0.00%
UBS Group AG 6.31K Mar 31, 2026 0.15% $0.00 3,634.91%
Wells Fargo & Co 2.30K Mar 31, 2026 0.05% $0.00 0.00%
Westside Investment Management, Inc. 1.65K Mar 31, 2026 0.04% $0.00 0.00%
Nbc Securities Inc 1.50K Mar 31, 2026 0.03% $0.00 0.00%
Western Wealth Management, LLC 1.33K Mar 31, 2026 0.03% $0.00 0.00%
Tower Research Capital LLC 1.03K Mar 31, 2026 0.02% $0.00 -64.26%
MCGUIRE CAPITAL ADVISORS INC 1.00K Mar 31, 2026 0.02% $0.00 0.00%
Barclays PLC 380.00 Mar 31, 2026 0.01% $0.00 0.00%
Group One Trading, LP 283.00 Dec 31, 2025 0.01% $0.00 -5.03%
Cornerstone Planning Group LLC 167.00 Mar 31, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 100.00 Mar 31, 2026 0.00% $0.00 0.00%
BlackRock Inc 60.00 Mar 31, 2026 0.00% $0.00 0.00%

Shares Statistics

Shares Outstanding: 4.30M
Shares Float: 4.15M
% Insiders: 299.20%
% Institutions: 619.90%
Short % Float: 2.16%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Institutional Extnd Mkt Idx Tr 31.10K 0.72% ▲ 0.00% Apr 30, 2026
2 Fidelity Extended Market Index 16.25K 0.38% ▼ 0.36% Apr 30, 2026
3 Spartan Extended Market Index Pool F 3.38K 0.08% ▲ 1.78% Apr 30, 2026
4 Fidelity Series Total Market Index 2.98K 0.07% ▲ 0.00% Apr 30, 2026
5 Northern Trust Extended Eq Market Idx 2.77K 0.06% ▲ 192.71% Mar 31, 2026
6 NT Ext Equity Mkt Index Fund - Lending 2.77K 0.06% ▼ 83.22% Mar 31, 2026
7 NT Ext Eq Mkt Idx Fd DC Lending Tier 5 1.09K 0.03% ▼ 83.09% Mar 31, 2026
8 Spartan Total Market Index Pool G 1.06K 0.02% ▲ 0.00% Apr 30, 2026
9 Fidelity Total Market Index 1.00K 0.02% ▲ 0.00% Apr 30, 2026
10 NT Ext Equity Mkt Index Fund - NL 398.00 0.01% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $-2.51M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $6.75M
Book Value: $2.07
Earnings/Share: $-3.79
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -66.50%
ROE (TTM): -160.83%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.18x 0.00x 0.31x N/A 0.00x
2024-12-31 1.19x 0.00x 0.84x N/A 0.00x
2023-12-31 2.53x 0.00x 0.39x N/A 0.00x
2022-12-31 4.55x 0.00x 0.22x -9,879.72x 0.00x
2021-12-31 15.71x 0.00x 0.06x -193.69x 0.00x
2020-12-31 6.82x 0.02x 0.16x N/A -0.01x
2019-12-31 1.48x 0.00x 0.68x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ACXP.US!